Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net income (loss)	$ (1,429)	$ 999
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,677	2,991
Stock-based compensation expense	2,176	1,756
Inventory impairments and abandonments	0	1,356
Deferred and other income tax expense (benefit)	(2,707)	318
Write-off of deposit on legacy land investment	2,700	0
Gain on sale of fixed assets	(46)	(771)
Change in allowance for doubtful accounts	(4)	(131)
Income (Loss) from Equity Method Investments	22	60
Cash distributions of income from unconsolidated entities	6	0
Changes in operating assets and liabilities:
Decrease in accounts receivable	1,433	1,955
Decrease in income tax receivable	4	150
Increase in inventory	(39,543)	(28,168)
Decrease in other assets	1,906	1,660
Decrease in trade accounts payable	(17,444)	(32,144)
Decrease in other liabilities	(12,541)	(27,760)
Net cash used in operating activities	(62,834)	(77,849)
Cash flows from investing activities:
Capital expenditures	(2,874)	(2,663)
Proceeds from sale of fixed assets	46	2,437
Investments in unconsolidated entities	(1,397)	(1,779)
Return of capital from unconsolidated entities	1,621	1,142
Increases in restricted cash	(3,646)	(1,119)
Decreases in restricted cash	2,088	669
Net cash used in investing activities	(4,162)	(1,313)
Cash flows from financing activities:
Repayment of debt	(2,525)	(26,926)
Debt issuance costs	(340)	(413)
Other financing activities	(387)	(201)
Net cash used in financing activities	(3,252)	(27,540)
Decrease in cash and cash equivalents	(70,248)	(106,702)
Cash and cash equivalents at beginning of period	228,871	251,583
Cash and cash equivalents at end of period	$ 158,623	$ 144,881